Tourmaline Bio, Inc. (TRML)
47.98
0.00 (0.00%)
USD |
NASDAQ |
Dec 10, 16:00
Tourmaline Bio Total Assets (Quarterly): 269.30M for June 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Novartis AG | 107.29B |
| Merck & Co., Inc. | 129.55B |
| UnitedHealth Group, Inc. | 315.27B |
| Gilead Sciences, Inc. | 58.53B |
| Eli Lilly & Co. | 114.94B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.10M |
| Shareholders Equity (Quarterly) | 259.19M |
| Debt to Equity Ratio | 0.0006 |
| Current Ratio | 24.68 |
| Net Debt Paydown Yield | 0.01% |